Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABEL: Bemiparin in Limited Small Cell Lung Cancer
NCT00324558Phase 2Terminated
- Sponsor
- Universidad de Navarra
- Start
- Jun 2005
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bemiparin in small cell lung cancer (SCLC), sponsored by Universidad de Navarra. Started Jun 2005; status: terminated.
02
Drugs
bemiparin
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00324558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00324558.